Is substantial lymphovascular space invasion in FIGO stage I endometrial carcinoma ready for primetime in deciding adjuvant treatment?

Gynecol Oncol. 2024 Sep:188:A1-A3. doi: 10.1016/j.ygyno.2024.08.015.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Chemotherapy, Adjuvant
  • Endometrial Neoplasms* / drug therapy
  • Endometrial Neoplasms* / pathology
  • Endometrial Neoplasms* / therapy
  • Female
  • Humans
  • Lymphatic Metastasis
  • Neoplasm Invasiveness*
  • Neoplasm Staging*